Dabigatran Etexilate Mesylate API

Name	Dabigatran etexilate mesylate
Chinese name	甲磺酸达比加群酯
Cas Number	872728-81-9
Source	India
Qualifications	USDMF/-/-/-/-

Dabigatran etexilate is the most cutting-edge new generation of oral anticoagulant direct thrombin inhibitors (DTIs). It is the first oral direct thrombin inhibitor approved in more than 50 years after warfarin. It is a milestone. Clinically, it is mainly used for stroke caused by atrial fibrillation, secondary venous thrombosis (VTE) and acute coronary syndrome after orthopedic surgery, prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. At present, dabigatran etexilate has been approved for marketing in more than 100 countries around the world, becoming a new type of oral anticoagulant with rich clinical application experience. Due to the definite efficacy and high safety of dabigatran etexilate, its clinical application has become more and more extensive in recent years, and sales in the international market have also been rising.

Hot Tags: dabigatran etexilate mesylate api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Tavaborol API, Cinacalcet Hydrochloride API, Clofarabine API, Bivalrudine API, Lifitegrast API, Letrozole API

• Previous: Mebeverine API
• Next: Saxagliptin Hydrochloride API